Browsing by Keyword : Angiotensin Receptor Antagonists
Showing results 1 to 14 of 14
| Pub Year | | Title | Author(s) |
| 2022 | | Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort | 박래웅, 임홍석 |
| 1999 | | Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist. | 이수환, 정이숙 |
| 2021 | | Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up | 임홍석 |
| 2023 | | Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis | 최창영 |
| 2024 | | Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study | 박래웅, 손상준 |
| 2012 | | Comparison of hyperkalemic risk in hospitalized patients treated with different angiotensin receptor blockers: a retrospective cohort study using a Korean clinical research database | 김흥수, 박래웅, 박인휘, 신규태, 신승수, 임홍석 |
| 2021 | | Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19 | 김대중 |
| 2018 | | Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study | 박인휘 |
| 2012 | | Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies | 신준한 |
| 2016 | | Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension | 강대용 |
| 2014 | | Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring? | 김흥수, 박래웅, 박인휘, 신규태, 신승수 |
| 1999 | | Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. | 이수환, 정이숙 |
| 2014 | | SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): a multi-center, retrospective, observational study | 신준한 |
| 2015 | | The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users. | 김흥수, 박래웅, 박인휘, 신규태, 신승수 |
1
